NOT FOR RELEASE OR DISTRIBUTION IN THE USA, CANADA, AUSTRALIA OR JAPAN.

SHOP APOTHEKE EUROPE N.V.: General Meeting confirms company's European growth strategy.

• Resolutions proposed by management accepted by large majorities.
• Management and Supervisory Boards confirmed for another term.

Venlo, the Netherlands, 30 April 2019. Today's Annual General Meeting of SHOP APOTHEKE EUROPE N.V. confirms the growth strategy of Europe's leading online pharmacy. 54.37% of share capital, equivalent to 6,565,392 of shares were represented. The members of the Management Board reviewed the 2018 fiscal year and explained the strategy and forecast for the 2019 fiscal year to the shareholders in attendance. The General Meeting approved the resolutions put forth by management by large majorities.

The agenda of this year's General Meeting included the (re-)appointment of the members of the Management and Supervisory Boards all of whose terms were extended unanimously. "As a management team driven by an entrepreneurial spirit, we are committed to strong growth with a focus on profitability," emphasized Stefan Feltens, CEO of SHOP APOTHEKE EUROPE. "The shift from offline to online retailing is a major growth driver for us. We will continue to win new customers and further expand and solidify our market-leading position in Europe by leveraging our renowned European shop brands and our unique webshop platform."

Following a strong first quarter during which the Group increased its revenues by approximately 33% compared to the same period 2018 according to preliminary calculations, the Management Board confirmed its ambitious growth targets for the current fiscal year: "Thanks to our successful recent capital-raising measures, our finances are on solid footing and we have created the conditions to continue our strong organic growth both domestically and internationally. Revenues of one billion euros is the next mid-range milestone we want to reach," explains CFO Dr. Ulrich Wandel.

You can find more information about the General Meeting in the Investor Relations section of the corporate website https://shop-apotheke-europe.com/en/.
ABOUT SHOP APOTHEKE EUROPE.

SHOP APOTHEKE EUROPE one of the leading and fastest-growing online pharmacy in Continental Europe. With the acquisition of Europa Apotheek Venlo in November 2017, SHOP APOTHEKE EUROPE significantly extended its European market leadership. The product range for the whole family in the OTC, beauty and personal care products as well as prescription drugs segments is supplemented by high quality natural food and health products, low carb products and sports nutrition following the acquisition of nu3 GmbH in July 2018.

SHOP APOTHEKE EUROPE already operates online pharmacies in Germany, Austria, France, Belgium, Italy, Spain, the Netherlands and Switzerland.

SHOP APOTHEKE EUROPE delivers a broad range of more than 100,000 original products to over 3.8 million active customers fast and at attractive prices. In addition, SHOP APOTHEKE EUROPE provides comprehensive pharmaceutical consulting services.

SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 13 October 2016 and on the SDAX since 24 September 2018.

MEDIA CONTACTS.

Trade and popular media:
Sven Schirmer
Phone: +49 221 99 53 44 31
Email: presse@shop-apotheke.com

Financial media:
Thomas Schnorrenberg
Mobile: +49 151 46 53 13 17
Email: presse@shop-apotheke.com

Investor relations:
Dr. Ulrich Wandel
Phone: +31 77 850 6117
Email: ulrich.wandel@shop-apotheke.com